HLHS Cause to Cure

Hypoplastic Left Heart Syndrome Program from Mayo Clinic

Share this:
January 27, 2016

How Studying Genes Helps Us to Understand HLHS

By suzannerferguson

Here at the Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome, we are working on new ways to delay and even prevent heart transplants for people with congenital heart defects. In order to do that, we are studying cell-based treatments, human genetics and advanced imaging techniques along with creating the world's largest biorepository for HLHS patients and families.

3462326_0007

To better understand the major role that genetics plays in the work we are doing and how we are finding individualized treatments for patients, we’ve put together this short video.

 

Do you have questions or are you interested in our program? Email us at HLHS@mayo.edu.

------------------------------------------------------------------------------------------------------------

The Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome (HLHS) is a collaborative network of specialists bonded by the vision of delaying or preventing heart failure for individuals affected by congenital heart defects including HLHS. The specialized team is addressing the various aspects of these defects by using research and clinical strategies ranging from basic science to diagnostic imaging to regenerative therapies.

Tags: CHD, Congenital Heart Disease, genetics, HLHS, Mayo Clinic, Recent Research, Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome

Please login or register to post a reply.
Contact Us · Privacy Policy